RecruitingNot ApplicableNCT06880679
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease
Sponsor
Indiana University
Enrollment
30 participants
Start Date
Apr 8, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Eligibility
Max Age: 25 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Point of Care Ultrasound for people with acute chest syndrome and sickle cell disease. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 25 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEPoint of Care Ultrasound
Point of Care Ultrasound during hospitalization
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06880679
Related Trials
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
NCT0643908232 locations
Blood Sampling for Research Related to Sickle Cell Disease
NCT005422301 location
TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
NCT053847561 location
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
NCT076161541 location
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT065466709 locations